COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,280 Articles (22,759 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 3108: Articles 31071-31080  | Next

Comparative study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting uncontrolled inflammation might not be the main reason of tissue injury
Zheng, Y., Huang, Z., Ying, G., Zhang, X., Ye, W., Hu, Z., Hu, C., Wei, H., Zeng, Y., Chi, Y., Cheng, C., Lin, F., Lu, H., Xiao, L., Song, Y., Wang, C., Yi, Y., Dong, L.
10.1101/2020.02.19.20024885 — Posted: 2020-02-23 Discussion: Onsite | Offsite
From Isolation to Coordination: How Can Telemedicine Help Combat the COVID-19 Outbreak?
Zhai, Y., Wang, Y., Zhang, M., Gittell, J. H., Jiang, S., Chen, B., Cui, F., He, X., Zhao, J., Wang, X.
10.1101/2020.02.20.20025957 — Posted: 2020-02-23
The role of institutional trust in preventive and treatment-seeking behaviors during the 2019 novel coronavirus (2019-nCoV) outbreak among residents in Hubei, China
Wong, L. P., Wu, Q. h., Chen, X., Chen, Z., Alias, H., Shen, M., Hu, J. c., Duan, S., Zhang, J. j., Han, L.
10.1101/2020.02.15.20023333 — Posted: 2020-02-21
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
Thao, T. T. N., Labroussaa, F., Ebert, N., V'kovski, P., Stalder, H., Portmann, J., Kelly, J., Steiner, S., Holwerda, M., Kratzel, A., Gultom, M., Laloli, L., Huesser, L., Wider, M., Pfaender, S., Hirt, D., Cippa, V., Crespo-Pomar, S., Schroeder, S., Muth, D., Niemeyer, D., Mueller, M. A., Drosten, C., Dijkman, R., Jores, J., Thiel, V.
10.1101/2020.02.21.959817 — Posted: 2020-02-21 Discussion: Onsite | Offsite
Functional pangenome analysis provides insights into the origin, function and pathways to therapy of SARS-CoV-2 coronavirus
Alam, I., Kamau, A. K., Kulmanov, M., Arold, S. T., Pain, A. T., Gojobori, T., Duarte, C. M.
10.1101/2020.02.17.952895 — Posted: 2020-02-21 Discussion: Onsite
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Watanabe, Y., Berndsen, Z. T., Raghwani, J., Seabright, G. E., Allen, J. D., McLellan, J. S., Wilson, I. A., Bowden, T. A., Ward, A. B., Crispin, M.
10.1101/2020.02.20.957472 — Posted: 2020-02-21
Potential T-cell and B-cell Epitopes of 2019-nCoV
Fast, E., Chen, B.
10.1101/2020.02.19.955484 — Posted: 2020-02-21 Discussion: Onsite
A Multiscale and Comparative Model for Receptor Binding of 2019 Novel Coronavirus and the Implication of its Life Cycle in Host Cells
Su, Z., Wu, Y.
10.1101/2020.02.20.958272 — Posted: 2020-02-21
Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV)
He, J., Tao, H., Yan, Y., Huang, S.-Y., Xiao, Y.
10.1101/2020.02.17.952903 — Posted: 2020-02-21 Discussion: Onsite
Protection of Rhesus Macaque from SARS-Coronavirus challenge by recombinant adenovirus vaccine
Chen, Y., Qin, C., Wei, Q., Li, R., Gao, H., Zhu, H., Deng, W., Bao, L., Wei, T.
10.1101/2020.02.17.951939 — Posted: 2020-02-21 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).